Command Palette

Search for a command to run...

ANUHPHR
80.36(-2.27%)
1W: -1.49%

Anuh Pharma Peer Comparison

Snapshot Summary

Anuh Pharma Ltd. is currently lagging behind its peers in key financial metrics. While it shows no significant debt, its lack of growth and profitability metrics indicates a need for improvement. In contrast, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories exhibit strong growth and profitability, making them sector leaders. Anuh Pharma's current valuation appears attractive, but without evident growth, it may not be a compelling investment at this time.

  • Anuh Pharma has no growth metrics reported, indicating stagnation.
  • Sun Pharmaceuticals and Dr. Reddy's Laboratories are outperformers with significant growth and profitability.
  • Anuh Pharma maintains a low debt level, but it lacks competitive profitability and growth indicators.
  • Sun Pharmaceutical Industries Ltd.: Strong revenue growth (YoY: 8.42%) and high profitability metrics with a ROE of 16.13%.
  • Dr. Reddy's Laboratories Ltd.: Solid growth trajectory with 16.54% revenue growth YoY and a strong ROE of 21.76%.
  • Cipla Ltd.: Promising revenue growth of 13.28% YoY and a decent ROE of 16.63%.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ANUHPHR₹87.34₹437.68Cr18.49--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.